SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Roadster reveal and its dramatic thruster-assisted demonstration are driving attention, with many traders impressed while skeptics call it a marketing stunt and question its practicality, street legality, and delayed production timeline. Some also speculate the TeslaSpaceX collaboration signals a possible merger, though no deal is confirmed.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp pullback has focused traders on upcoming share unlocks and potential insider selling, alongside concerns about SpaceXs valuation; bulls are buying the dip and citing TeslaSpaceX merger speculation after the Roadster reveal, while bears warn of dilution and hype.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on anticipation for the full Phase 3 melanoma cancer-vaccine data at ESMO, following positive topline results; traders are debating whether the pipeline can justify the sharp rise. Bulls point to continued momentum, while skeptics call the valuation stretched and warn of a possible sell-the-news reaction.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid a steep post-IPO selloff and concerns that staggered lockup expirations could add shares to the market, with traders debating the potential for insider selling. Bulls say the selling risk is overstated and emphasize demand for its AI inference technology, while bears point to its OpenAI customer concentration and broader weakness in AI and semiconductor stocks.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Hot inflation readings and Fed Chair Warshs comments on the rate path are fueling volatile trading, with traders split between viewing the rebound as a durable dip-buying move and a temporary bounce amid rate-hike concerns and AI-sector weakness.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

RGCs sharp move is fueling speculation about another meme-stock run, with traders pointing to its history of abrupt rallies, concentrated insider ownership, and a potentially constrained float as conditions for a short squeeze. Others call the move a pump-and-dump and question the companys fundamentals, so the squeeze talk remains speculative rather than a confirmed catalyst.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly is drawing attention amid a broad selloff in space and other high-growth stocks, with traders citing inflation and interest-rate concerns alongside sector weakness. The debate centers on dip-buying and long-term NASA/space business prospects versus worries about continued downside, profitability, and launch execution.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives rally is being discussed alongside a live governance proposal that could double INJs deflation rate, with traders also citing ongoing buybacks and burns, RWA development, and ETF filings as bullish themes. Optimism about tighter supply and ecosystem growth contrasts with skeptics who point to INJs prolonged decline and question whether those fundamentals will translate into sustained demand.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

BTDR is drawing attention after a steep selloff and weak performance versus other miners, with traders often blaming the announced at-the-market share offering and fearing further dilution. The debate pits concerns about dilution, debt and losses against bullish views of Bitdeers Bitcoin-mining scale and AI/data-center contracts, while some traders point to broader crypto-sector weakness.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas record-high breakout and BMOs price-target increase, citing resilient consumer spending and growth in value-added services, are drawing attention. Traders are largely bullish on the momentum, though some warn the stock may be overextended and vulnerable to a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BNTX just hasn&#39;t learned how to manipulate trials like $MRNA

$BNTX has inferior technology.  mRNA was a moon shot; only  $MRNA was successful. BioNTech is on a plane at full speed into the ground. 
Yes, there is hope in the future - but how long do you need to wait. The risk is that Moderna mRNA expertise increasingly pulls away from BNTX. Will continue to watch and when they have first breakthrough jump in or maybe  reboard sometime next year if the cash burn is not too bad. 
A massive residual risk is the mRNA technology role - still unfilled? REALLY? Guido Oelkers looks like a great leader but has zero mRNA experience, not a mRNA scientific pioneer. Yikes. At this moment, BNTX is a no touch. 
Was fortunate and lucky to exit a bit before the CEO and CMO announced their departure. Do not expect anything good in the near term.

StockTwits Web

BioNTech SE - ADR

Indy

Modernas rally is centered on anticipation for full Phase 3 melanoma-vaccine results at ESMO, building on an earlier positive topline readout and Goldman Sachs increased price target. Bulls view the personalized cancer-vaccine program as validation of the oncology pipeline, while skeptics say the surge has outrun fundamentals and warn of a potential sell-the-news pullback.

 just hasn't learned how to manipulate trials like 